Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma

Conditions

• Melanoma
• Metastatic Melanoma
• Solid Tumor
• Neoplasm

Interventions

• DRUG: MLN2480

Sponsor

Millennium Pharmaceuticals, Inc.